Epstein–Barr virus biomarkers for nasopharyngeal carcinoma in non-endemic regions
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epstein–Barr virus biomarkers for nasopharyngeal carcinoma in non-endemic regions
Authors
Keywords
-
Journal
JOURNAL OF GENERAL VIROLOGY
Volume 98, Issue 8, Pages 2118-2127
Publisher
Microbiology Society
Online
2017-08-08
DOI
10.1099/jgv.0.000889
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic Value of Plasma Epstein–Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
- (2016) Wen-Hui Chen et al. MEDICINE
- The tumour trail left in blood
- (2016) Kelly Rae Chi NATURE
- Risk stratification based on change in plasma Epstein-Barr virus DNA load after treatment in nasopharyngeal carcinoma
- (2016) Yuan Zhang et al. Oncotarget
- Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status
- (2016) Hao Peng et al. Oncotarget
- Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma
- (2015) FEI-PENG ZHAO et al. Oncology Letters
- Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma
- (2015) Wen-Hui Chen et al. Oncotarget
- The role of Epstein-Barr virus in epithelial malignancies
- (2014) Sai-Wah Tsao et al. JOURNAL OF PATHOLOGY
- Clinical outcomes for early-stage nasopharyngeal carcinoma with predominantly WHO II histology treated by intensity-modulated radiation therapy with or without chemotherapy in nonendemic region of China
- (2013) Shanquan Luo et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation
- (2012) Ai-Di Gu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fluctuations of Epstein-Barr Virus Serological Antibodies and Risk for Nasopharyngeal Carcinoma: A Prospective Screening Study with a 20-Year Follow-Up
- (2011) Su-Mei Cao et al. PLoS One
- Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma
- (2010) W.-Y. Wang et al. CLINICAL CANCER RESEARCH
- Different Clinical Significance of Pre- and Post-treatment Plasma Epstein–Barr Virus DNA Load in Nasopharyngeal Carcinoma Treated with Radiotherapy
- (2010) Xue Hou et al. CLINICAL ONCOLOGY
- HLA Associations with Nasopharyngeal Carcinoma
- (2009) Xin Li et al. CURRENT MOLECULAR MEDICINE
- Regulatory T cells and EBV associated malignancies
- (2009) Jiang Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: A need for reappraisal
- (2009) Cindy M. Chang et al. VIRUS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search